https://www.selleckchem.com/pr....oducts/combretastati
3%) and 34 with CSE (35.4%) developed infections. Multivariate analysis identified the following independent risk factors gastrostomy, history of intravenous therapy or hemodialysis, and previous exposure to broad-spectrum β-lactam antibiotics, including penicillin with β-lactamase inhibitors, cephalosporins, and carbapenems. In propensity score-adjusted analysis, mortality rates for the CRE and CSE groups were similar (15.0% and 19.5%, respectively). We found that IMP-CRE may not contribute to worsened clinical outcomes, comp
Like
Comment
Share
